EYETECH PHARMACEUTICALS INC 4
4 · EYETECH PHARMACEUTICALS INC · Filed Jul 1, 2005
Insider Transaction Report
Form 4
SBLENDORIO GLENN
Chief Financial Officer
Transactions
- Sale
Common Stock
2005-07-01$12.59/sh−1,850$23,292→ 43,095 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2005-07-01−1,850→ 62,329 totalExercise: $1.36From: 2002-02-21Exp: 2012-02-21→ Common Stock (1,850 underlying) - Exercise/Conversion
Common Stock
2005-07-01$1.36/sh+1,850$2,516→ 44,945 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2005-07-01−1,850→ 117,771 totalExercise: $1.36From: 2002-02-21Exp: 2012-02-21→ Common Stock (1,850 underlying)
Footnotes (1)
- [F1]Transaction effected pursuant to a 10b5-1 plan dated April 25, 2005.